200720

Evaluation of survivin as a prognostic marker in head and neck lymphomas

Article

Last updated: 05 Jan 2025

Subjects

-

Tags

-

Abstract

El Hendawy H. A.[1], Gaballah E. T.2,El Nagdy S. Y.3, Abdelhadi M. Shebl4. 1Teaching Assistant of Oral Pathology, Oral Pathology Department, Faculty of Dentistry, Mansoura University,Egypt. 2 Professor &head of Oral Pathology, Oral Pathology Department, Faculty of Dentistry, Mansoura University,, Egypt. 3Professor of Oral Pathology, Oral pathology Department, Faculty of Dentistry, Mansoura University, Egypt. 4Assistant professor of General pathology, General pathology Department, Faculty of Medicine, Mansoura University,Egypt. Abstract: Objectives:Examine the potential role of survivin in head and neck lymphomas by exploring the level of its expression in different clinicopathologic parameters. Methods:Formalin-fixed and paraffin-embedded tissue sections of 43 specimens of head and neck lymphoma were immunohistochemically analyzed forsurvivin expression using Avidin-Biotin complex (ABC) method Results:Survivin was highly expressed in lymphomas with aggressive behavior while low to intermediate level of expression was demonstrated in lymphomas with indolent behavior. High significant differences (p <0.004) were found by Conclusions:Survivin expression in head and neck lymphomas seems to be clinically relevant as it presents a tendency to be less expressed in indolent than aggressive tumors.

DOI

10.21608/mjd.2014.200720

Volume

1

Article Issue

2

Related Issue

28312

Issue Date

2014-04-01

Receive Date

2021-10-23

Publish Date

2014-04-01

Page Start

31

Page End

37

Print ISSN

2735-4172

Online ISSN

2812-5479

Link

https://mjd.journals.ekb.eg/article_200720.html

Detail API

https://mjd.journals.ekb.eg/service?article_code=200720

Order

5

Type

Original Article

Type Code

1,715

Publication Type

Journal

Publication Title

Mansoura Journal of Dentistry

Publication Link

https://mjd.journals.ekb.eg/

MainTitle

Evaluation of survivin as a prognostic marker in head and neck lymphomas

Details

Type

Article

Created At

23 Jan 2023